Diabetes
Mrmario973
TF89652269.potx
Presentation Cover Option 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Contoso Pharmaceuticals
Contoso Pharmaceuticals
1
Presentation Cover Option 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
page 2
Contoso Pharmaceuticals
2
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius.
Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit.
Ut congue quis tortor eget sodales.
About Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut.
page 3
Contoso Pharmaceuticals
3
The Problem
Declining Market
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Financial
Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend.
Trust
Integer convallis suscipit ante eu varius. Morbi a purus dolor.
Cost
Suspendisse sit amet ipsum varius finibus justo viverra blandit.
Margins
Ut congue quis tortor varius eget sodales.
page 4
Contoso Pharmaceuticals
4
Prioritize
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Authorize
Etiam aliquet eu mi quis lacinia.
Monetize
Integer convallis suscipit ante eu varius.
Solution
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis.
page 5
Contoso Pharmaceuticals
5
Unique
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
First to Market
Etiam aliquet eu mi. Ut fermentum a magna ut eleifend.
Tested
Integer convallis suscipit eu varius. Morbi a purus dolor.
Authentic
Suspendisse sit amet ipsum varius finibus justo viverra blandit.
Product
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis.
page 6
Contoso Pharmaceuticals
6
Emphasize your main benefit
Other benefits include
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Nunc tempus, risus sodales hendrerit, arcu dolor commodo libero.
page 7
Contoso Pharmaceuticals
7
Section Divider
Lorem ipsum dolor sit amet, consectetur adipiscing elit
page 8
Contoso Pharmaceuticals
8
Business Model
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Research
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Finance
Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend.
Invest
Integer convallis suscipit ante eu varius. Morbi a purus dolor.
page 9
Contoso Pharmaceuticals
9
Market Opportunity Option 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
$1B
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius.
Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit.
$2B
Ut congue quis tortor eget sodales. Nulla a erat eget nunc hendrerit ultrices eu nec nulla.
Donec viverra leo aliquet, auctor quam id, convallis orci.
page 10
Contoso Pharmaceuticals
10
Market Opportunity Option 2
Integer convallis suscipit ante eu varius. Morbi a purus dolor.
Opportunity to Build
$3B
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Freedom to Invent
$2B
Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend.
Few Competitors
$1B
Integer convallis suscipit ante eu varius. Morbi a purus dolor.
page 11
Contoso Pharmaceuticals
11
Competition Option 1
Contoso Pharmaceuticals
Nulla a erat eget nunc hendrerit ultrices eu nec nulla. Donec viverra leo aliquet, auctor quam id, convallis orci.
Sed in molestie est. Cras ornare turpis at ligula posuere, sit amet accumsan neque lobortis.
Maecenas mattis risus ligula, sed ullamcorper nunc efficitur sed.
Competitor
Praesent venenatis quam tortor, id viverra nunc rutrum a.
Maecenas malesuada ultricies sapien sit amet pharetra.
Nunc tempus, risus sodales hendrerit, arcu dolor commodo libero, a sollicitudin quam nulla quis lectus. In at porta mauris.
page 12
Contoso Pharmaceuticals
12
Competition Option 2
Convenience
Inconvenient
Expensive
Affordable
Contoso Pharmaceuticals
page 13
Contoso Pharmaceuticals
13
Growth Strategy
How will we scale in the future
Phase 1 Month, Year
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius.
Phase 2 Month, Year
Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit.
Ut congue quis tortor eget sodales. Nulla a erat eget nunc hendrerit ultrices eu nec nulla.
Phase 3 Month, Year
Donec viverra leo aliquet, auctor quam id, convallis orci.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
page 14
Contoso Pharmaceuticals
14
Traction
Forecasting for success
| Vendors | Users | Gross Revenue | Company Revenue | |
| 20YY | 0 | 0 | $0 | $0 |
| 20YY | 10 | 100 | $6,750 | $1,013 |
| 20YY | 50 | 500 | $33,750 | $5,063 |
| 20YY | 200 | 2000 | $135,000 | $20,250 |
| 20YY | 400 | 4000 | $270,000 | $40,500 |
page 15
Contoso Pharmaceuticals
15
Gross Revenue
0 6750 33750 135000 270000 Series 1 20YY 20YY 20YY 20YY 20YY
Timeline
Our two-year action plan
AUG
SEP
Trials
Month, 20YY
OCT
NOV
Legislation
Month, 20YY
DEC
20YY
JAN
FEB
MAR
APR
MAY
JUN
Marketing
Month, 20YY
JUL
AUG
Investment
Month, 20YY
SEP
OCT
NOV
DEC
Procurement
Month, 20YY
20YY
JAN
FEB
MAR
APR
MAY
Launch
Month, 20YY
page 16
Contoso Pharmaceuticals
16
Financials
| Year 1 | Year 2 | Year 3 | ||
| Detailers | 5,000 | 40,000 | 160,000 | |
| Users | 50,000 | 400,000 | 1 600,000 | |
| Sales | 500,000 | 4 000,000 | 16 000,000 | |
| Average Price per Sale | 75 | 80 | 90 | |
| Revenue @ 15% | 5 625,000 | 48 000,000 | 216 000,000 | |
| Cost of Revenue | 0 | 0 | 0 | |
| Gross Profit | 5 625,000 | 48 000,000 | 216 000,000 | |
| Expenses | ||||
| Sales & Marketing | 5 062,500 | 38 400,000 | 151 200,000 | 70% |
| Customer Service | 1 687,500 | 9 600,000 | 21 600,000 | 10% |
| Product Development | 562,500 | 2 400,000 | 10 800,000 | 5% |
| Research | 281,250 | 2 400,000 | 4 320,000 | 2% |
| Total Expenses | 7 593,750 | 52 800,000 | 187 920,000 | |
| EBIT | -1 968,750 | -4 800,000 | 28 080,000 | 13% |
page 17
Contoso Pharmaceuticals
17
Team
Mirjam Nils
COO
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius.
Victoria Lindqvist
COB
Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit. Ut congue quis tortor eget sodales. Nulla a erat eget nunc hendrerit ultrices eu nec nulla.
Angelica Astrom
CFO
Donec viverra leo aliquet, auctor quam id, convallis orci. Sed in molestie est. Cras ornare turpis at ligula posuere, sit amet accumsan neque lobortis.
page 18
Contoso Pharmaceuticals
18
Team Alternate
Mirjam Nilsson
COO
Victoria Lindqvist
COB
Alexander Martensson
CFO
Angelica Astrom
Head of Operations
Mira Karlsson
Head of Technical
Flora Berggren
Creative Director
page 19
Contoso Pharmaceuticals
19
Funding
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Fund Category
. Integer convallis suscipit ante eu varius. Morbi a purus dolor.
Fund Category
Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut.
Fund Category
Suspendisse sit amet ipsum finibus justo viverra blandit. Ut congue quis tortor eget sodales.
Fund Category
page 20
Contoso Pharmaceuticals
20
82000 32000 14000 12000 Sales Part 1 Part 2 Part 3 Part 4
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia.
Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius. Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit.
Ut congue quis tortor eget sodales. Nulla a erat eget nunc hendrerit ultrices eu.
Summary
Summary tagline or sub-headline
page 21
Contoso Pharmaceuticals
21
Thank You
April Hansson
+1 23 987 6554
www.contoso.com
page 22
Contoso Pharmaceuticals
22
Customize this Template
Template Editing Instructions and Feedback
page 23
Contoso Pharmaceuticals
23
.MsftOfcThm_Accent4_Fill { fill:#126974; }
.MsftOfcThm_Accent5_Fill { fill:#C13131; }
.MsftOfcThm_Accent1_Fill { fill:#31B0C1; }
.MsftOfcThm_Accent2_Fill { fill:#CB488B; }
.MsftOfcThm_Accent3_Fill { fill:#BC9230; }
.MsftOfcThm_Accent1_Fill { fill:#31B0C1; }
.MsftOfcThm_Accent2_Fill { fill:#CB488B; }
.MsftOfcThm_Accent3_Fill { fill:#BC9230; }
.MsftOfcThm_Accent4_Fill { fill:#126974; }
.MsftOfcThm_Accent1_Fill { fill:#31B0C1; }
.MsftOfcThm_Accent3_Fill { fill:#BC9230; }
.MsftOfcThm_Accent3_Fill { fill:#BC9230; }
.MsftOfcThm_Accent2_Fill { fill:#CB488B; }
.MsftOfcThm_Accent3_Fill { fill:#BC9230; }
.MsftOfcThm_Text1_lumMod_50_lumOff_50_Fill { fill:#7F7F7F; }
.MsftOfcThm_Text1_lumMod_50_lumOff_50_Fill { fill:#7F7F7F; }
.MsftOfcThm_Text1_lumMod_50_lumOff_50_Fill { fill:#7F7F7F; }
.MsftOfcThm_Text1_lumMod_50_lumOff_50_Fill { fill:#7F7F7F; }
.MsftOfcThm_Background2_Fill { fill:#F2F2F2; }
.MsftOfcThm_Accent1_Fill { fill:#31B0C1; }
.MsftOfcThm_Accent3_Fill { fill:#BC9230; }
.MsftOfcThm_Accent2_Fill { fill:#CB488B; }
